by Alexandrea Macpherson | Jul 25, 2024 | NEWS
We are delighted to announce that PREDICT-Meso Clinical study Meso-ORIGINS is a now registered study in the NIHR Associate Principal Investigator (PI) Scheme. The Associate PI Scheme is a six month in-work training opportunity, providing practical experience for...
by Alexandrea Macpherson | Jun 17, 2024 | NEWS, OUTPUTS
Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group Samuel G. Armato III, Sharyn I. Katz, Thomas Frauenfelder, Geeshath Jayasekera, Annamaria Catino, Kevin...
by Alexandrea Macpherson | May 13, 2024 | NEWS, OUTPUTS
We urgently need new therapies #mesothelioma. Check out our new article in @LancetRespirMed ‘Leveraging the pleural space for anticancer therapies in pleural mesothelioma’, which makes the case for expansion of intrapleural trials, covering who, why and...
by Alexandrea Macpherson | Apr 17, 2024 | NEWS
This edition features updates on work package progress, a new exciting collaboration and some photos of our PREDICT-Meso visit to Scottish Parliament. Click button below to access April 2024 Newsletter
by Alexandrea Macpherson | Apr 17, 2024 | NEWS
See below for links to PREDICT-Meso Newsletters to date (April 2024) #1 April 2023: Our first Newsletter noting PREDICT-Meso aims and objectives #2 July 2023, featuring: iMig and the PREDICT-Meso pre-clinical models school; new leveraged funding #3 October 2023,...
by Alexandrea Macpherson | Jan 11, 2024 | NEWS, OUTPUTS
PREDICT-Meso Co-I Daniel J. Murphy co-authoured a paper accepted for publication in Cell Death and Disease, with Olivier E. Pardo and Yakinthi Chrisochoidou at Imperial. This work was carried out as part of WP4- Target Drug Validation Abstract Mesothelioma is an...
